|
⚲
|
| Deep Track Capital LP
✚
|
|
|---|---|
| CRD # | 312459 |
| SEC # | 801-120500 |
| CIK # | 0001856083 |
| AUM | $5.1 BB (2024-03-28) |
| Employees | 19 (68% Investors, 0% Brokers) |
| Phone | 203-409-0810 |
| Address | 200 Greenwich Avenue Greenwich, CT 06830 |
| Source | [IAPD] [EDGAR] [Website] |
| Total AUM ($BB) |
|---|
| CIK | Period |
|---|---|
| 0001856083 | |
| / | |
| Sector | Form 13F Holdings | Cap ($BB) | Value ($BB) |
|---|---|---|---|
| Amgen Inc | 130.1 | 0.2 | |
| Argenx SE | 19.8 | 0.2 | |
| Axsome Therapeutics Inc | 1.5 | 0.1 | |
| Dyne Therapeutics Inc | 0.3 | 0.1 | |
| Springworks Therapeutics Inc | 1.3 | 0.1 | |
| Insmed Inc | 2.4 | 0.1 | |
| Guardant Health Inc | 4.3 | 0.1 | |
| Dynavax Technologies Corp | 1.5 | 0.1 | |
| Alnylam Pharmaceuticals Inc | 17.2 | 0.1 | |
| Intellia Therapeutics Inc | 3.9 | 0.1 | |
| Oneida Resources Corp | 5.2 | 0.1 | |
| Apellis Pharmaceuticals Inc | 4.7 | 0.1 | |
| ISIS Pharmaceuticals Inc | 5.4 | 0.1 | |
| Ocular Therapeutix Inc | 0.3 | 0.1 | |
| 4D Molecular Therapeutics Inc | 0.2 | 0.1 | |
| Alkermes PLC | 5.0 | 0.1 | |
| Nurix Therapeutics Inc | 0.5 | 0.1 | |
| Health Sciences Acquisitions Corp | 0.3 | 0.1 | |
| Bicycle Therapeutics PLC | 0.5 | 0.1 | |
| Pliant Therapeutics Inc | 0.3 | 0.1 | |
| Desert Gateway Inc | 1.5 | 0.1 | |
| Verona Pharma PLC | 0.3 | 0.1 | |
| Abivax Sa | 0.1 | ||
| Geron Corp | 0.6 | 0.1 | |
| Autolus Therapeutics PLC | 0.3 | 0.1 | |
| Manhattan Pharmaceuticals Inc | 0.6 | 0.1 | |
| Signal Genetics Inc | 0.3 | 0.1 | |
| Kymera Therapeutics Inc | 1.0 | 0.0 | |
| MIND Medicine Mindmed Inc | 0.3 | 0.0 | |
| Olema Pharmaceuticals Inc | 0.2 | 0.0 | Prev | Page 1 | Next |
| Type | Form D Funds | Date | Sold ($MM) | AUM ($MM) |
|---|---|---|---|---|
| HF | Deep Track Biotechnology Master Fund Ltd | 2021-07-08 | 5,116.1 |
| AUM Breakdown | Accounts | AUM ($BB) |
|---|---|---|
| By Client Type | ||
| (a) Individuals (other than high net worth individuals) | 0 | 0.0 |
| (b) Individuals (high net worth individuals) | 0 | 0.0 |
| (c) Banking or thrift institutions | 0 | 0.0 |
| (d) Investment companies | 0 | 0.0 |
| (e) Business development companies | 0 | 0.0 |
| (f) Pooled investment vehicles | 3 | 5.1 |
| (g) Pension and profit sharing plans | 0 | 0.0 |
| (h) Charitable organizations | 0 | 0.0 |
| (i) State or municipal government entities | 0 | 0.0 |
| (j) Other investment advisers | 0 | 0.0 |
| (k) Insurance companies | 0 | 0.0 |
| (l) Sovereign wealth funds and foreign official institutions | 0 | 0.0 |
| (m) Corporations or other businesses not listed above | 0 | 0.0 |
| (n) Other | 0 | 0.0 |
| Total | 3 | 5.1 |
| By Discretionary | ||
| Discretionary | 3 | 5.1 |
| Non-Discretionary | 0 | 0.0 |
| Total | 3 | 5.1 |
| By Non-United States Persons | ||
| Non-United States Persons | 3.0 | |
| United States Persons | 2.1 | |
| Total | 3 | 5.1 |
| EDGAR Form | CIK | 2011 - 2024 |
|---|---|---|
| 13F-HR | [0001856083] | |
| 3 | [0001856083] | |
| 4 | [0001856083] | |
| SC 13D | [0001856083] | |
| SC 13G | [0001856083] |
| Form 3/4/5 Subject | 2011 - 2024 |
|---|---|
| Kroin David | |
| Deep Track Capital, LP | |
| Nektar Therapeutics | |
| Deep Track Biotechnology Master Fund, Ltd. |
| Comparable Firms | State | AUM ($BB) |
|---|---|---|
|
Daemon Investment and Asset Management LLC
✚
|
FL | 5.2 |
|
NAYA Capital Management UK Limited
✚
|
5.2 | |
|
Landmark Management LLC
✚
|
NY | 5.2 |
|
Napier Park Global Capital Ltd
✚
|
5.1 | |
|
Cephei Capital Management Hong Kong Limited
✚
|
5.1 | |
|
TPG PEP Advisors LLC
✚
|
TX | 5.0 |
|
EcoR1 Capital LLC
✚
|
CA | 5.0 |
|
Empyrean Capital Partners LP
✚
|
CA | 5.0 |
|
Caledonia US LP
✚
|
NY | 5.0 |
|
STWD Investment Management LLC
✚
|
FL | 5.0 |